EAGER:A Novel Lab-on-a-Chip Concept for Characterization of Nanovesicles based on their Dielectric Properties
EAGER:A Novel Lab-on-a-Chip Concept for Characterization of Nanovesicles based on their Dielectric Properties
批准号:
2020112
负责人:
Leyla Esfandiari
金额:
$9.95万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-15 至 2022-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this project is to develop a rapid and accurate lab-on-a-chip device for characterization of nano-size vesicles based on their unique and intrinsic biophysical properties. The immediate focus of this project is to characterize small cell-secreted vesicles (exosomes) which are classified as circulating biomarkers associated with many types of disease including cancer, diabetes, cardiovascular, infectious, and neurodegenerative diseases. This research also has the potential to be expanded beyond exosomes to detect and study other small membrane bound vesicles including viruses. Thus, this high throughput detection tool can be utilized in a wide range of medical diagnosis and biomedical research which could potentially reduce the cost of healthcare by providing frequent, affordable, and early testing to patients. Furthermore this multidisciplinary project crosses the traditional boundaries between engineering, physics, and biomedical sciences which will provide students with a unique educational experience during their academic training. The undergraduate students will be trained and exposed to the field of micro- nanotechnology and biomedical sciences by closely working with the graduate students and being mentored by the principal investigator. The proposed project will also educate public about the importance of the field of micro-nanotechnologies for medicine through YouTube channel and “ThinkTV” program which will be broadcasting in Southwest Ohio. Exosomes are extracellular vesicles with diameters of ~30-120 nm, released from many cell types into the extracellular space. They are composed of a lipid bilayer membrane containing various receptors and tetraspanin proteins. They also encapsulate nucleic acids, proteins, and lipids in their lumen. Exosomes are promising biomarkers for several reasons: 1) they are highly abundant in all bodily fluids and therefore easily accessible; 2) their composition reflects their cellular origins and can therefore serve as indicators of pathology; and 3) they are stable. Also, it has been shown that exosomes secreted from different cellular origins, in particular pathogenic exosomes, undergo compositional changes and could have additional membrane receptors and/or elevated or suppressed levels of nucleic acids which can be associated with their total electric charges and dipoles. However, use of exosomes as biomarkers has been hampered by the lack of workable technologies to reliably isolate and rigorously characterize their unique properties in a timely manner. Although, some of the biophysical properties of exosomes such as size, density and morphology have been characterized before, their dielectric property which is associated with their unique compositional charges has not yet been investigated. The proposed label-free lab-on-a-chip device will utilize controllable electrokinetic forces across an array of borosilicate micropipettes to rapidly entrap exosomes at the tip of the pipettes and characterize the vesicles based on their unique dielectric properties by measuring their impedance. The impedance measurement will be conducted across an array of microelectrodes embedded in close proximity to the pipettes’ tips as an alternative current (AC) is applied at a wide range of frequency spectrum (500 KHz to 50 MHz). The AC field at a wide frequency range will polarize the bound and unbound charges associate with exosomes’ structure. The difference in impedance measurements will be linked to exosomes’ unique dielectric properties which includes their membrane capacitance and cytosolic conductance. Additionally, the impedance of exosomes secreted from different cellular origins and size distribution will be measured and their uniqueness in dielectric properties will be investigated. This rapid and label-free electrokinetic device can be further evolved as a diagnostic tool for initial non-invasive detection of pathogenic exosomes while keeping their compositions intact for further downstream analysisThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A Label-Free Electrical Impedance Spectroscopy for Detection of Clusters of Extracellular Vesicles Based on Their Unique Dielectric Properties.
无标记的电阻抗光谱,用于根据其独特的介电特性检测细胞外囊泡的簇。
DOI:
10.3390/bios12020104
发表时间:
2022-02-09
期刊:
Biosensors
影响因子:
--
作者:
[Zhang Y, Murakami K, Borra VJ, Ozen MO, Demirci U, Nakamura T, Esfandiari L]
通讯作者:
Esfandiari L
CAREER: An electrokinetically driven micro-device for rapid purification and characterization of exosomes
-
批准号:2046037
-
项目类别:Continuing Grant
-
资助金额:$50.0万
-
财政年份:2021
-
负责人:Leyla Esfandiari
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: